Roger Dansey, Seagen interim CEO

Seagen stays qui­et on M&A as it push­es Keytru­da-Pad­cev com­bo, con­tin­ues CEO search

Seagen’s keep­ing qui­et on the M&A front as ru­mors fly around a po­ten­tial Mer­ck buy­out. In­stead, the Wash­ing­ton State-based phar­ma com­pa­ny used its Q2 call …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.